In a patient with hypertension on losartan 100 mg daily and amlodipine 10 mg daily who remains uncontrolled while taking hydralazine 50 mg twice daily, what is the best medication to replace hydralazine?

Replace Hydralazine with Spironolactone or Chlorthalidone

In this patient with resistant hypertension on losartan 100 mg and amlodipine 10 mg who remains uncontrolled despite hydralazine 50 mg twice daily, the best replacement option is spironolactone 12.5-25 mg daily, or alternatively chlorthalidone 12.5-25 mg daily if the patient has contraindications to mineralocorticoid receptor antagonists. 1

Rationale for Spironolactone as First Choice

The 2018 AHA Scientific Statement on resistant hypertension clearly positions mineralocorticoid receptor antagonists (spironolactone or eplerenone) as the preferred fourth agent in resistant hypertension, before hydralazine 1. Your patient is currently using hydralazine as a fourth drug, which according to the treatment algorithm should actually be a fifth-line agent.

Why Spironolactone Works Better

• Spironolactone provides superior blood pressure reduction compared to α- or β-blockers in patients with low renin status or salt sensitivity 1
• Can be initiated at low doses (12.5-25 mg daily) with once-daily administration 1
• Approximately 70% of adults with resistant hypertension are candidates based on kidney function and potassium levels 1

Critical Safety Checks Before Starting Spironolactone

Do NOT use spironolactone if:

• eGFR <45 mL/min/1.73 m² 1
• Baseline serum potassium >4.5 mEq/L 1

Monitor for:

• Hyperkalemia (especially important given concurrent losartan use)
• Gynecomastia and erectile dysfunction in men with prolonged use at higher doses 1
• Menstrual irregularities in women 1

Alternative: Chlorthalidone

If spironolactone is contraindicated or not tolerated, switch from hydralazine to chlorthalidone 12.5-25 mg daily. The evidence strongly supports thiazide-like diuretics over hydralazine at this stage:

• Chlorthalidone and indapamide have the greatest evidence base for reducing cardiovascular outcomes 1
• Switching from hydrochlorothiazide to the same dose of chlorthalidone provides an additional 7-8 mmHg systolic BP reduction 1
• Your patient is not currently on any diuretic, representing a significant gap in the treatment regimen

Why Hydralazine Should Be Replaced

According to the AHA algorithm, hydralazine is positioned as a fifth-line agent (step 5), to be used only after:

1. ARB/ACE inhibitor + CCB + diuretic (steps 1-2)
2. Mineralocorticoid receptor antagonist added (step 3)
3. β-blocker or central α-2 agonist if heart rate >80 bpm (step 4)
4. Then hydralazine (step 5) 1

Additional Concerns with Hydralazine

• Causes increased sympathetic tone and sodium retention, requiring background β-blocker and diuretic therapy 1
• Total daily doses should be <150 mg to avoid drug-induced lupus (your patient is at 100 mg/day, approaching this threshold) 1
• The evidence shows IV hydralazine is more effective than oral for acute BP reduction 2, but your patient needs chronic management

Practical Implementation

Step 1: Check labs (serum potassium, eGFR)

Step 2: If labs appropriate:

• Stop hydralazine
• Start spironolactone 12.5-25 mg once daily
• Continue losartan 100 mg and amlodipine 10 mg
• Monitor potassium in 1-2 weeks

Step 3: If spironolactone contraindicated:

• Stop hydralazine
• Start chlorthalidone 12.5-25 mg once daily
• Continue losartan 100 mg and amlodipine 10 mg

Step 4: If BP remains uncontrolled after 4 weeks on optimized therapy, consider adding a β-blocker (if heart rate >80 bpm) before reconsidering hydralazine 1

Common Pitfall to Avoid

The most common error is continuing to add agents without following the evidence-based sequence. Your patient jumped to hydralazine (step 5) without trying spironolactone (step 3) or addressing the absence of diuretic therapy. This represents suboptimal resistant hypertension management and likely explains the persistent uncontrolled BP.